More Fake Cancer Drugs Found In The U.S. | WAMU 88.5 - American University Radio

NPR : News

Filed Under:

More Fake Cancer Drugs Found In The U.S.

Another batch of phony cancer drugs has made its way into the U.S., the Food and Drug Administration says.

U.S.-based medical practices purchased vials of counterfeit medicine labeled as Altuzan from a foreign supplier, FDA spokesperson Shelly Burgess tells Shots. She said the agency doesn't have any reports of patients having received the counterfeit drugs.

Altuzan is the Turkish brand name for Avastin, the FDA-approved blockbuster cancer drug from Swiss drugmaker Roche's Genentech unit. Altuzan is approved for use in Turkey — but not in the U.S.

The shipments came from Richards Pharma, a foreign supplier also known by the names Richards Services, Warwick Healthcare Solutions and Ban Dune Marketing, according to an FDA statement. Lab tests confirmed March 15 that the vials contained none of the active ingredient in Altuzan, Burgess says.

Packaging or vials found in the U.S. that claim to be Roche's Altuzan with lot number B6021 should be considered counterfeit, the FDA statement says.

As Richard Knox reported in Shots, counterfeit Avastin turned up in the U.S. in February. More than a dozen specialists in Illinois, California and Texas were thought to have bought it. Avastin, or bevacizumab, is approved to treat colorectal, lung, kidney and brain cancer.

Avastin is expensive — a 400-milligram vial costs $2,400, and sales of the drug totaled more than $2.5 billion last year.

Fake versions of diet drugs, the cholesterol drug Lipitor and the flu medication Tamiflu also have turned up in the U.S. in the past.

"In the past three months, we've notified health care providers about the risk of purchasing unapproved injectable cancer medications from unlicensed sources," Burgess says. "This is a practice that has to stop."

She says health care providers or patients who think they have received counterfeit drugs should report it to the FDA's MedWatch safety program.

Copyright 2012 National Public Radio. To see more, visit http://www.npr.org/.

NPR

This Weekend, Experience The Enduring Power Of 'The Millstone'

Margaret Drabble's The Millstone, set in the 1960s, tells the story of a young, unmarried woman who finds herself pregnant. Author Tessa Hadley says this 50-year-old novel is a weekend must-read.
NPR

Italian Cheese Lovers Find Their Bovine Match Through Adopt A Cow

The cheeses of the Italian Alps are prized for their flavor. But the tradition of cheese-making here is dying off. Now remaining farmers are banding together around an unusual adoption program.
NPR

Is The Battle Won And Done For Those Who Fought For Net Neutrality?

In a 3-2 vote on Feb. 26, the FCC approved new rules, regulating broadband internet as a public utility. NPR's Arun Rath speaks with Mat Honan, San Francisco bureau chief for BuzzFeed News, about the political implications of the vote.
NPR

A Neuroscientist Weighs In: Why Do We Disagree On The Color Of The Dress?

Robert Siegel speaks with Dr. Bevil Conway, a neuroscientist at Wellesley College, about the dress that has the whole Internet asking: What color is it?

Leave a Comment

Help keep the conversation civil. Please refer to our Terms of Use and Code of Conduct before posting your comments.